YZYachun Zhou

Yachun Zhou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yachun Zhou has a total of 27 co-authors. Here are the top co-authors by number of shared publications:

  • Liang Yang

    Southern University of Science and Technology

    3 shared publications
  • Anmin Ren

    Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, PR China

    1 shared publication
  • Anmin Ren

    Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China

    1 shared publication
  • Ashao Jia

    Department of Laboratory Medicine, Shenzhen University General Hospital, Shenzhen 518000, China

    1 shared publication
  • Junfeng Wang

    State Key Laboratory of Tropical Oceanography/Guangdong Key Laboratory of Marine Materia Medica, South China Sea Institute of Oceanology, Chinese Academy of Sciences, Guangzhou 510301, China

    1 shared publication
  • Lei Lei

    Baoan Center for Disease Control and Prevention of Shenzhen, Shenzhen 518100, PR China

    1 shared publication

Latest Publications

  • Open Access

    Catheter-Associated Soft Tissue Infection Caused by Pantoea piersonii in a Totally Implantable Venous Access Port: The First Report from China

    by Yachun Zhou, Anmin Ren, Xianting Huang, Ashao Jia, Yingfeng Huang, Pingping Chen, Ruoyu Jia, Li Deng, Liang Yang, Xianyuan Zhou, et al.

    Pantoea piersonii (formerly Kalamiella piersonii) is a recently reclassified environmental Gram-negative bacterium belonging to the family Erwiniaceae. Human infections caused by this organism are extremely rare. Here, we report a rare case of implantable venous access port-associated soft tissue infection caused by P. piersonii in a 49-year-old immunocompromised woman with lung cancer. The pathogen was isolated from purulent discharge obtained from the port site and identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). Whole-genome sequencing confirmed species-level identification based on average nucleotide identity (ANI) analysis and phylogenomic reconstruction. The isolate exhibited broad antimicrobial susceptibility to the tested agents. Following complete device removal and empirical antimicrobial therapy, the patient recovered uneventfully. This study reports the first documented case of P. piersonii infection in China and provides a comprehensive clinical and genomic characterization of a newly isolated clinical strain.

  • Bongkrekic acid reprograms hepatic lipid metabolism to promote systemic organ injury

    by Lei Lei, Qingliang Chen, Anmin Ren, Xiaoting Huang, Xinxi He, Zilin Zhuang, Lingguo Zhao, Yinqui Wang, Tianyuan Jia, Yachun Zhou, et al.

  • Open Access

    New 24-Membered Macrolactines from an Arctic Bacterium Bacillus amyloliquefaciens SCSIO 41392 and Their Anti-Pathogenicity Evaluation

    by Yue Song, Yachun Zhou, Mengjing Cong, Shengyi Deng, Yushi Chen, Xiaoyan Pang, Yonghong Liu, Li Liao, Liang Yang, Junfeng Wang

    Three new 24-membered macrolactines, amylomacrolactines A–C (1–3), along with two known compounds 4 and 5, were isolated from the Arctic bacteria Bacillus amyloliquefaciens SCSIO 41392. The configurations of 1–3 were assigned by a combination of coupling constants, NOESY, and analysis of MM2-optimized conformation, as well as by comparison with reports in the literature. Compounds 1 and 2 showed quorum sensing (QS) inhibitory activities against the Pseudomonas aeruginosa (P. aeruginosa) PQS system and suppressed PQS-regulated virulence factor pyocyanin synthesis. In addition, compounds 3–5 affected the production of another essential virulence factor, siderophore of pyoverdine (PVD), in P. aeruginosa. More importantly, compound 5 showed an anti-biofilm activity against P. aeruginosa. Altogether, the isolated compounds displayed multiple bacterial virulence inhibition activities, which is worthy of further exploration for novel analogues in antimicrobial drug development.